1642 related articles for article (PubMed ID: 32496587)
1. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
[TBL] [Abstract][Full Text] [Related]
2. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
[TBL] [Abstract][Full Text] [Related]
3. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
Kasela S; Ortega VE; Martorella M; Garudadri S; Nguyen J; Ampleford E; Pasanen A; Nerella S; Buschur KL; Barjaktarevic IZ; Barr RG; Bleecker ER; Bowler RP; Comellas AP; Cooper CB; Couper DJ; Criner GJ; Curtis JL; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Krishnan JA; Martinez FJ; McDonald MN; Meyers DA; Paine R; Peters SP; Castro M; Denlinger LC; Erzurum SC; Fahy JV; Israel E; Jarjour NN; Levy BD; Li X; Moore WC; Wenzel SE; Zein J; ; ; Langelier C; Woodruff PG; Lappalainen T; Christenson SA
Genome Med; 2021 Apr; 13(1):66. PubMed ID: 33883027
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
5. Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.
Saheb Sharif-Askari F; Goel S; Saheb Sharif-Askari N; Hafezi S; Al Heialy S; Hachim MY; Hachim IY; Mahboub B; Salameh L; Abdelrazig M; Elzain EI; Al-Muhsen S; Al-Hajjaj MS; Ratemi E; Hamid Q; Halwani R
Front Immunol; 2021; 12():796094. PubMed ID: 35111161
[TBL] [Abstract][Full Text] [Related]
6. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
Konwar C; Asiimwe R; Inkster AM; Merrill SM; Negri GL; Aristizabal MJ; Rider CF; MacIsaac JL; Carlsten C; Kobor MS
Epigenetics Chromatin; 2021 Dec; 14(1):54. PubMed ID: 34895312
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
Berthelot JM; Lioté F; Maugars Y; Sibilia J
Front Immunol; 2020; 11():607069. PubMed ID: 33335532
[TBL] [Abstract][Full Text] [Related]
8. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
9. Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype.
Camiolo M; Gauthier M; Kaminski N; Ray A; Wenzel SE
J Allergy Clin Immunol; 2020 Aug; 146(2):315-324.e7. PubMed ID: 32531372
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
[TBL] [Abstract][Full Text] [Related]
11. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.
Ulrich H; Pillat MM
Stem Cell Rev Rep; 2020 Jun; 16(3):434-440. PubMed ID: 32307653
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
14. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
Ilikci Sagkan R; Akin-Bali DF
J Med Virol; 2020 Nov; 92(11):2637-2647. PubMed ID: 32492203
[TBL] [Abstract][Full Text] [Related]
15. Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design.
Maleksabet H; Rezaee E; Tabatabai SA
Curr Pharm Des; 2022; 28(45):3583-3591. PubMed ID: 36420875
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking.
Hamet P; Pausova Z; Attaoua R; Hishmih C; Haloui M; Shin J; Paus T; Abrahamowicz M; Gaudet D; Santucci L; Kotchen TA; Cowley AW; Hussin J; Tremblay J
Am J Hypertens; 2021 Apr; 34(4):367-376. PubMed ID: 33386398
[TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
Finney LJ; Glanville N; Farne H; Aniscenko J; Fenwick P; Kemp SV; Trujillo-Torralbo MB; Loo SL; Calderazzo MA; Wedzicha JA; Mallia P; Bartlett NW; Johnston SL; Singanayagam A
J Allergy Clin Immunol; 2021 Feb; 147(2):510-519.e5. PubMed ID: 33068560
[TBL] [Abstract][Full Text] [Related]
18. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
Avolio E; Carrabba M; Milligan R; Kavanagh Williamson M; Beltrami AP; Gupta K; Elvers KT; Gamez M; Foster RR; Gillespie K; Hamilton F; Arnold D; Berger I; Davidson AD; Hill D; Caputo M; Madeddu P
Clin Sci (Lond); 2021 Dec; 135(24):2667-2689. PubMed ID: 34807265
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
20. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
Subbarayan K; Ulagappan K; Wickenhauser C; Bachmann M; Seliger B
Front Immunol; 2021; 12():597399. PubMed ID: 33796097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
